Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas

scientific article published on 01 September 2005

Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1309/BL7EMW66LQX6GFRP
P698PubMed publication ID16191507

P50authorGunnar B KristensenQ90928617
Anne-Lise Børresen-DaleQ11958220
Åslaug HellandQ38155382
Jahn M. NeslandQ73925706
P2093author name stringYun Wang
Ruth Holm
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)392-401
P577publication date2005-09-01
P1433published inAmerican Journal of Clinical PathologyQ15750224
P1476titleProtein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas
P478volume124

Reverse relations

cites work (P2860)
Q54411632Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS.
Q35847701Blocking epidermal growth factor receptor activation by 3,3'-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo
Q38652339EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
Q36614450Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients
Q54583226Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.
Q79915423Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival
Q34587948Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer
Q43280944Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer
Q34557233Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization
Q37269642Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
Q34586019Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma
Q38226577Oncogenes associated with drug resistance in ovarian cancer
Q36121260PI3K expression and PIK3CA mutations are related to colorectal cancer metastases
Q35095308PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup
Q37328373Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies
Q46159400Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers
Q44929440Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a meta-analysis
Q80010199Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer
Q35791117Relevant molecular markers and targets
Q42055866Targeting the fanconi anemia pathway to identify tailored anticancer therapeutics.
Q36785983The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
Q89861767The Expression of ERK1/2 in Female Yak (Bos grunniens) Reproductive Organs
Q33906083The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer.
Q33577824The role of the PTEN/PI3K/Akt pathway on prognosis in epithelial ovarian cancer: a meta-analysis

Search more.